12.38
0.00 (0.00%)
| 前收盘价格 | 12.38 |
| 收盘价格 | 11.78 |
| 成交量 | 5,739 |
| 平均成交量 (3个月) | 161,333 |
| 市值 | 7,679,962 |
| 市盈率 (P/E TTM) | 12.38 |
| 价格/销量 (P/S) | 1.74 |
| 股市价格/股市净资产 (P/B) | 0.980 |
| 52周波幅 | |
| 利润日期 | 15 Jun 2025 - 21 Jun 2025 |
| 营业毛利率 | 0.02% |
| 营业利益率 (TTM) | -26.46% |
| 季度收入增长率 (YOY) | 85.30% |
| 总债务/股东权益 (D/E MRQ) | 13.92% |
| 流动比率 (MRQ) | 4.91 |
| 营业现金流 (OCF TTM) | -1.33 M |
| 杠杆自由现金流 (LFCF TTM) | -1.22 M |
| 资产报酬率 (ROA TTM) | -0.14% |
| 股东权益报酬率 (ROE TTM) | 0.01% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Devices (GB) | 混合的 | 混合的 |
| Medical Devices (全球的) | 看跌 | 看跌 | |
| 股票 | RUA LIFE SCIENCES PLC ORD 5P | - | - |
AIStockmoo 评分
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -0.5 |
| 平均 | -0.63 |
相关股票
| 股票 | 市值 | DY | P/E（TTM） | P/B |
|---|---|---|---|---|
| RUA LIFE SCIENCES PLC ORD 5P | 8 M | - | 12.38 | 0.980 |
| 0K5E | 765 M | 4.01% | 7.06 | - |
| CREO MEDICAL GROUP PLC ORD GBP0 | 53 M | - | - | 1.22 |
| INTELLIGENT ULTRASOUND GROUP PL | 36 M | - | - | 7.29 |
| NOVACYT S.A. EUR1/15TH (CDI) | 34 M | - | - | 0.600 |
| INSPIRATION HEALTHCARE GROUP PL | 15 M | - | - | 1.13 |
|
RUA Life Sciences PLC is a biomedical polymer technology, components, and medical device company. The company's principal activities comprise exploiting the value of its IP and know-how, medical device contract manufacturing, and development of cardiovascular devices. Its business segments are Royalty and License Income (Biomaterials), Contract Manufacture, Product Development (Vascular), and Product Innovation (Structural Heart). It derives the majority of its revenue from the Contract Manufacture segment. Geographically, it derives the majority of its revenue from the USA and has a presence in Switzerland, Italy, the UK, and Israel. |
|
| 部门 | Healthcare |
| 行业 | Medical Devices |
| 投资方式 | Small Value |
| 内部持股比例 | 59.16% |
| 机构持股比例 | 24.92% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合